Champions Oncology Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Champions Oncology Inc with three other
pharmaceutical manufacturers in North America:
sales of $29.13 million
of which 100%
was commercial-stage diagnostics),
Medexus Pharmaceuticals Inc
(33.86 million Canadian Dollars [US$25.42 million]
Champions Oncology Inc reported sales of $27.07 million
April of 2019.
increase of 33.7%
versus 2018, when the company's sales were $20.24 million.
This was the fourth straight year of sales growth at Champions Oncology Inc.